José Manuel Domínguez Vera
The BionaMet team develops bioplatforms as biocarriers of optically and magnetically active nanoparticles for imaging and therapy. These bioplatforms are based on proteins and living probiotic
bacteria, which specifically accumulate in the liver and bowel, respectively. Molecule-based drugs can also be incorporated into the nanostructures (bioplatform + nanoparticles), thus obtaining
targeted multifunctional nanoprobes for theranotics.
We use TEM techniques for characterize the nanostructures, including HAADF, EDX, EELS and HREM modes.
Research group members:
Natividad Gálvez, Rafael Cuesta, Ana González, Rocio Jurado, Manuel Sánchez, Victor Garces
You can contact us at:
7 March 2017: Conchita Gimeno is one of the awardees of the IUPAC 2017 Distinguished Women in Chemistry
20 October 2016: Second MetDrugs meeting
2 February 2016: First MetDrugs meeting
14 october 2015: The Ministry of Economy and Competitiveness of Spain finances the network